After SARS-CoV-2 infection, anti-chemokine antibodies correlate with better outcomes
A recent study posted to the bioRxiv* preprint server illustrated that specific chemokine antibodies aid in recognizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent individuals with a desirable disease course.
Source: news-medical.net